MAYWOOD, IL – Loyola University Medical Center is the first academic medical center in the Chicago area to offer a precise radiation treatment for prostate cancer called high dose rate (HDR) prostate brachytherapy, in which the radiation dose is delivered in just minutes and removed immediately after the treatment.
HDR prostate brachytherapy differs from the most common form of prostate brachytherapy – low dose rate (LDR) – because the radioactive “seed” is removed immediately after treatment rather than multiple seeds being implanted in the prostate and remaining radioactive for months.
“What sets HDR brachytherapy apart is the ability to sculpt the radiation dose to reliably avoid healthy organs, such as the bladder, rectum and urethra,” said Loyola radiation oncologist Abhishek Solanki, MD. “Since the radiation source is removed immediately after completion of treatment, patients do not have to take radiation precautions after they leave the hospital.”
Loyola’s HDR prostate brachytherapy program was developed by Dr. Solanki and Matthew Harkenrider, MD, in collaboration with urologists Robert Flanigan, MD, Gopal Gupta, MD, and Ahmer Farooq, DO.
Another benefit of HDR brachytherapy is that it requires only two treatments. By contrast, two standard external beam radiation treatments, IMRT and proton therapy, take eight to nine weeks.
The outpatient HDR brachytherapy treatment involves a one-hour procedure performed by the radiation oncologist in conjunction with the urologist. This is followed by a CT scan and sophisticated radiation treatment planning to maximize the chance the cancer is cured, while minimizing potential side effects. The individualized radiation dose is then delivered using a robotic system, and the patient goes home later that day.
In some patients with more aggressive prostate cancer, HDR brachytherapy may be used in combination with a shorter course of external beam radiation in order to deliver a higher radiation dose to the prostate.
“This cutting-edge treatment offers a more convenient and customizable option for prostate cancer patients,” Dr. Harkenrider said. “HDR brachytherapy is a reliable and consistent method for delivering precise radiation doses to the prostate. It has been shown to be a safe and highly effective treatment.”
In addition to HDR brachytherapy for prostate cancer, Loyola offers radical prostatectomy, IMRT, proton therapy and LDR brachytherapy. All these treatments have been shown to be safe and effective, and each treatment has advantages and disadvantages.
“At Loyola, we are committed to offering our patients the full range of options for treatment of their prostate cancer,” said William Small Jr., MD, chair of the department of radiation oncology of Loyola University Medical Center. “While every patient will determine the best course of action with his physician, Loyola is proud to offer HDR brachytherapy as an option to our patients.”
About Loyola Medicine
Loyola Medicine, a member of Trinity Health, is a nationally ranked academic, quaternary care system based in Chicago's western suburbs. The three-hospital system includes Loyola University Medical Center (LUMC), Gottlieb Memorial Hospital, MacNeal Hospital, as well as convenient locations offering primary care, specialty care and immediate care services from nearly 2,000 physicians throughout Cook, Will and DuPage counties. LUMC is a 547-licensed-bed hospital in Maywood that includes the William G. and Mary A. Ryan Center for Heart & Vascular Medicine, the Cardinal Bernardin Cancer Center, the John L. Keeley, MD, Emergency Department, a Level 1 trauma center, Illinois's largest burn center, the Nancy W. Knowles Orthopaedic Institute, a certified comprehensive stroke center, transplant center and a children’s hospital. Having delivered compassionate care for over 50 years, Loyola also trains the next generation of caregivers through its academic affiliation with Loyola University Chicago’s Stritch School of Medicine and Marcella Niehoff School of Nursing.
For more information, visit loyolamedicine.org. You can also follow Loyola Medicine on LinkedIn, Facebook, Instagram or X (formerly known as Twitter).
About Trinity Health
Trinity Health is one of the largest not-for-profit, faith-based health care systems in the nation. It is a family of 127,000 colleagues and more than 38,300 physicians and clinicians caring for diverse communities across 26 states. Nationally recognized for care and experience, the Trinity Health system includes 93 hospitals, 107 continuing care locations, the second largest PACE program in the country, 142 urgent care locations and many other health and well-being services. In fiscal year 2024, the Livonia, Michigan-based health system invested $1.3 billion in its communities in the form of charity care and other community benefit programs. For more information, visit us at www.trinity-health.org, or follow us on LinkedIn, Facebook, and X (formerly known as Twitter).